Repatha®

Random entry RSS

Posted in:
News

Jury Finds Amgen Antibody Patents Not Invalid
By Benjamin R. Holt March 18, 2019 Comments are off
Over four years ago, in October 2014, Amgen initiated a patent infringement suit against Sanofi and Regeneron regarding biologics for...

Read more

Tagged with: Amgen, FDA, Federal Circuit, Praluent®, Regeneron, Repatha®, Sanofi, Supreme Court

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top